Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Merck”
Sponsor: Merck Sharp & Dohme LLC
Carcinoma, Non-Small-Cell Lung
United States, Chile, Germany, Greece, Hungary +5 more
Sponsor: University of Liverpool
Acute Pancreatitis
United Kingdom
Sponsor: Merck Sharp & Dohme LLC
Malignant Melanoma
United States, Australia, Canada, France, Germany +7 more
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Kidney Cancer
United States
Sponsor: Merck Sharp & Dohme LLC
Urinary Bladder Neoplasms · Non-Muscle Invasive Bladder Neoplasms · Carcinoma in Situ
United States, Argentina, Australia, Brazil, Canada +14 more
Sponsor: Merck Sharp & Dohme LLC
Healthy
United States
Sponsor: Merck Sharp & Dohme LLC
Colorectal Cancer
United States, Belgium, Canada, Colombia, Costa Rica +17 more
Sponsor: University of Texas Southwestern Medical Center
Anal Squamous Cell Carcinoma
Sponsor: Merck Sharp & Dohme LLC
Healthy
United States
- Merck IIT: RRP Pembro and LenvatinibRecruiting
Sponsor: Yale University
Human Papilloma Virus · Recurrent Respiratory Papillomatosis · Pulmonary Disease
United States
- Early Check: Expanded Screening in NewbornsActive Not Recruiting
Sponsor: RTI International
Spinal Muscular Atrophy · Fragile X Syndrome · Fragile X - Premutation · Duchenne Muscular Dystrophy
United States
- Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid TumorCompleted
Sponsor: Dana-Farber Cancer Institute
Advanced Solid Tumor
United States
- Nemtabrutinib and Venetoclax for the Treatment of Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaNot Yet Recruiting
Sponsor: Jennifer Woyach
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
United States
- Neoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast CaActive Not Recruiting
Sponsor: Virginia Commonwealth University
Breast Adenocarcinoma · Estrogen Receptor- Negative Breast Cancer · Estrogen Receptor-positive Breast Cancer · HER2/Neu Negative
United States
- Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years OldActive Not Recruiting
Sponsor: Boston Medical Center
Human Papilloma Virus
United States
Sponsor: Merck Sharp & Dohme LLC
Alzheimer Disease · Dementia
United States, Argentina, Canada, Italy, Japan +4 more
- Riociguat in Children With Pulmonary Arterial Hypertension (PAH)Active Not Recruiting
Sponsor: Bayer
Hypertension, Pulmonary
Colombia, Germany, Hungary, Italy, Japan +4 more
Sponsor: Merck Sharp & Dohme LLC
Colorectal Cancer · Pancreatic Ductal Adenocarcinoma · Biliary Tract Cancer
United States, Australia, Canada, Chile, China +8 more
- A Trial of Pembrolizumab and Metformin Versus Pembrolizumab Alone in Advanced MelanomaActive Not Recruiting
Sponsor: Yana Najjar
Advanced Melanoma
United States
Sponsor: Ranjana Advani
Hodgkin Lymphoma · Classic Hodgkin Lymphoma · Relapsed Classical Hodgkin Lymphoma · Refractory Classic Hodgkin Lymphoma
United States
- M9466 Alone or in Combination in Advanced Solid Tumors (DDriver 501)Active Not Recruiting
Sponsor: EMD Serono Research & Development Institute, Inc.
Advanced Solid Tumor
United States, Australia, Japan, South Korea, Spain
Sponsor: Merck Sharp & Dohme LLC
Urinary Bladder Cancer, Muscle-invasive
United States, Argentina, Australia, Belgium, Canada +23 more
Sponsor: Merck Sharp & Dohme LLC
Advanced Hepatocellular Carcinoma
United States, China, Italy, Japan, Poland +4 more
Sponsor: University of Alabama at Birmingham
Ovarian Cancer
United States
Sponsor: CytomX Therapeutics
Solid Tumor, Adult
United States